For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events (MDEs) known as CRAB: Diagnosis also required -- and still does -- the ...

This approach could be an important consideration in the management of heavily pretreated patients with chemorefractory multiple myeloma, even at the stage of terminal illness with extramedullary ...